Variable expression of Cre recombinase transgenes precludes reliable prediction of tissue-specific gene disruption by

Tim J Schulz1, Markus Glaubitz, Doreen Kuhlow

  • 1University of Jena, Institute of Nutrition, Jena, Germany.

Plos One
|October 11, 2007
PubMed

Insights

Cre recombinase expression can be lost across generations in transgenic mice, leading to failed gene disruption. Genotyping alone may not confirm gene knockout efficacy, necessitating post hoc analysis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Transgenic Technology

Background:

  • The Cre/loxP system is widely used for generating conditional knockout mouse models for tissue-specific gene disruption.
  • Ensuring reliable Cre recombinase activity is crucial for the accurate generation of these models.

Purpose of the Study:

  • To investigate the phenomenon of declining Cre recombinase expression in a transgenic mouse strain over successive generations.
  • To determine the impact of diminished Cre expression on the efficacy of target gene disruption.

Main Methods:

  • Utilized a transgenic mouse strain engineered for Cre/loxP-mediated gene disruption.
  • Monitored Cre recombinase expression across multiple generations.
  • Assessed target gene disruption at both the genomic and protein expression levels.

Main Results:

  • Observed a progressive loss of Cre recombinase expression in the transgenic strain with increasing generations.
  • Complete abrogation of Cre gene expression was detected at the molecular level, despite intact genomic DNA.
  • This loss of Cre expression resulted in incomplete or absent disruption of the target gene.

Conclusions:

  • Cre recombinase expression can be epigenetically silenced or otherwise lost in transgenic lines over time.
  • Genomic analysis of Cre transgenes may not reliably predict functional gene disruption.
  • Post hoc validation of target gene disruption is essential for all subjects in Cre/loxP studies to ensure experimental validity.